Related Experiment Video
Updated: Mar 16, 2026
05:31
Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
1.5K
ERVW-1 gene polymorphisms related to preeclampsia.
Bratislavske Lekarske Listy
|August 23, 2016
Summary
This study investigated the ERVW-1 gene
Area of Science:
- Genetics
- Obstetrics
- Molecular Biology
Background:
- Preeclampsia is a complex pregnancy disorder causing significant maternal and perinatal mortality.
- Abnormal placentation and disturbed syncytin 1 expression, a product of the ERVW-1 gene, are implicated in preeclampsia.
- The ERVW-1 gene's role in syncytiotrophoblast differentiation is critical for placental development.
Purpose of the Study:
- To analyze the regulatory regions of the ERVW-1 gene.
- To identify DNA polymorphisms in ERVW-1 associated with preeclampsia in the Slovak population.
- To explore the genetic basis of preeclampsia for potential diagnostic applications.
Main Methods:
- Sequencing of the ERVW-1 gene's regulatory regions.
- Analysis of DNA variants in samples from the Slovak population.
- Investigating genetic associations with preeclampsia.
Main Results:
- Four specific DNA variants (rs4727276, rs148592540, rs569899772, rs555416193) were identified in the Slovak population.
- No statistically significant association was found between these ERVW-1 polymorphisms and preeclampsia in the studied cohort.
Conclusions:
- The identified ERVW-1 variants were not directly associated with preeclampsia in this study.
- Larger sample sizes are necessary for further investigation into the genetic links between ERVW-1 and preeclampsia.
- This research offers a novel approach to the genetic differential diagnosis of preeclampsia.
More Related Videos
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
12.3K
09:37Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
10.6K
Related Concept Videos
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
94
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
94
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
63
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
63
01:27Principles of Pharmacogenetics: Types of Genetic Variants
73
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
73
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
94
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
94
02:26Comparing Copy Number Variations and SNPs
19.1K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
19.1K
01:05Single Nucleotide Polymorphisms-SNPs
19.5K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
19.5K